Development and evaluation of buccal bioadhesive tablet of an anti-emetic agent ondansetron

AAPS PharmSciTech

Volumn 10, Issue 4, 2009, Pages 1085-1092

  Hassan, Nisreen ^a   Khar, R K ^a   Ali, Mushir ^a   Ali, Javed ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Buccal adhesive tablet; Buccal delivery; Mucoadhesion; Ondansetron hydrochloride; Optimized formula

Indexed keywords

ALGINIC ACID; ANTIEMETIC AGENT; ASPARTAME; CARBOMER; CARBOXYMETHYLCELLULOSE; ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; MACROGOL 6000; MAGNESIUM STEARATE; ONDANSETRON;

ANIMAL TISSUE; ARTICLE; BUCCAL DRUG ADMINISTRATION; CHEEK MUCOSA; CONTROLLED STUDY; COW; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SCREENING; DRUG STABILITY; EX VIVO STUDY; FIRST PASS EFFECT; IN VITRO STUDY; MUCOADHESION; NONHUMAN; SALIVA; TABLET COMPRESSION; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET THICKNESS; VISCOSITY;

ADHESIVENESS; ADMINISTRATION, BUCCAL; ANIMALS; ANTIEMETICS; CATTLE; CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; HARDNESS; HUMANS; HYDROGEN-ION CONCENTRATION; ONDANSETRON; SOLUBILITY; TABLETS;

EID: 75649113901     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9304-4     Document Type: Article

References (27)

1. J Lachaine C Laurier A Langleben L Vaillant 1999 Cost-effectiveness and quality of life evaluation of ondansetron and metoclopramide for moderately emetogenic chemotherapy regimens in breast cancer J Oncol Hema 32 105 12 1:STN:280:DC%2BD3c%2FnvVWgtg%3D%3D
2. KC Mohan K Ravikumar 1995 Ondansetron hydrochloride: a competitive serotonin 5-HT3 receptor blocker Acta Cryst Sect C Cryst Struct Comm C51 2627 9 10.1107/S0108270195008043 1:CAS:528:DyaK28Xkt1Whuw%3D%3D
3. PhDNC Milap HN Leanna PhDK John 1996 Efficacy and safety of ondansetron in pediatric patients undergoing bone marrow transplantation Clinical Therapeutics 18 466 76 10.1016/S0149-2918(96)80027-0 (Pubitemid 26248906)
4. HH Alur SI Pather AK Mitra TP Johnston 1999 Transmucosal sustained-delivery of chlorpheniramine maleate in rabbits using a novel natural mucoadhesive gum as excipients in buccal tablets Int J Pharm 188 1 10 10.1016/S0378-5173(99)00211-2 1:CAS:528:DyaK1MXmvVartL8%3D 10528077 (Pubitemid 29472454)
5. Salem II, Lopez JMR, Galan AC. Ondansetron hydrochloride. In: Brittan HG, Academic Press an Imprint of Elsevier, editors. Analytical profiles of drug substances and excipients, vol. 27. California: San Diego; 2001. p. 301-339.
6. NS Miller M Chittchang TP Johnston 2005 The use of mucoadhesive polymers in buccal drug delivery Adv Drug Del 57 1666 91 10.1016/j.addr.2005.07.003 (Pubitemid 41443474)
7. CB Jain J Aungs MC Adeyeye 2002 Development and in vivo evaluation of buccal tablets prepared using danazol-, sulfobutylether 7-cyclodextrin (SBE7) complexes J Pharm Sci 91 1659 68 10.1002/jps.10163 1:CAS:528: DC%2BD38XltVyitLg%3D 12115827 (Pubitemid 34680228)
8. VM Patel BG Prajapati MM Patel 2007 Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride AAPS PharmSciTech 8 E22 10.1208/pt0804089 http://www. aaps pharmscitech.org
9. CR Park DL Munday 2004 Evaluation of selected polysaccharide excipients in buccoadhesive tablets for sustained release of nicotine Drug Dev Ind Pharm 30 609 17 10.1081/DDC-120037492 1:CAS:528:DC%2BD2cXksFSgtrs%3D 15285334 (Pubitemid 38924631)
10. T Nagai R Konishi 1987 Buccal/gingival drug delivery systems J Control Release 6 353 60 10.1016/0168-3659(87)90088-5 1:CAS:528:DyaL1cXhtFyrsLY%3D (Pubitemid 18017744)
11. HE Junginger JA Hoogstraate JC Verhoef 1999 Recent advances in buccal drug delivery and absorption: in vitro and In vivo studies J Control Release 62 149 59 10.1016/S0168-3659(99)00032-2 1:CAS:528:DyaK1MXmsV2qsro%3D 10518646 (Pubitemid 29486493)
12. TM Pramodkumar KGh Desai HG Shivakumar 2002 Buccal permeation enhancers Ind J Pharm Edu 36 147 51
13. P Munasur V Pillay DJ Chetty T Govender 2006 Statistical optimization of the mucoadhesivity and characterization of multipolymeric propranolol matrices for buccal therapy Int J Pharm 323 43 51 10.1016/j.ijpharm.2006.05.051 1:CAS:528:DC%2BD28XpvVOmsbc%3D 16863686 (Pubitemid 44419452)
14. Sohi H, Khar RK, Singh S. Development of controlled release tablets of anti-migraine agent. Proceeding of the 31st Annual Meeting and Exposition of the Controlled Release Society. 2004, June 12-16, Honolulu, Hawaii, USA; 290
15. M Jug M Becirevic-Lacan 2004 Influence of hydroxypropyl-β- cyclodextrin complexation on piroxicam release from buccoadhesive tablets Eur J Pharm Sci 21 251 260 10.1016/j.ejps.2003.10.029 1:CAS:528:DC%2BD2cXptFWrtg%3D%3D 14757497 (Pubitemid 38156162)
16. P Bottenberg R Cleymaet CD Muynck JP Remon D Coomans D Slop 1991 Development and testing of bio-adhesive, fluoride-containing slow release tablets for oral use J Pharm Pharmacol 43 457 64 1:CAS:528:DyaK3MXkvF2itr8%3D 1682457
17. B Parodi E Russo G Caviglioli S Cafaggi G Bignardi 1996 Development and characterization of a buccoadhesive dosage form of oxycodone hydrochloride Drug Dev Ind Pharm 22 445 50 10.3109/03639049609069353 1:CAS:528:DyaK28XivVOis78%3D
18. H Okamoto H Taguchi K Iida K Danjo 2001 Development of polymer film dosage forms of lidocaine for buccal administration I. penetration rate and release rate J Control Release 77 253 60 10.1016/S0168-3659(01)00509-0 1:CAS:528:DC%2BD3MXoslGntL8%3D 11733093 (Pubitemid 33145477)
19. G Sandri S Rossi MC Bonferoni F Ferrari Y Zambito GD Colo C Caramella 2005 Buccal penetration enhancement properties of N-trimethyl chitosan: influence of quaternization degree on absorption of a high molecular weight molecule Int J Pharm 297 146 55 1:CAS:528:DC%2BD2MXkt1ansrc%3D 15907601
20. GC Ceschel V Bergamante V Calabrese S Biserni 2006 Design and evaluation in vitro of controlled release mucoadhesive tablets containing chlorhexidene Drug Dev Ind Pharm 32 53 61 10.1080/03639040500388300 (Pubitemid 43220914)
21. G Sandri S Rossi F Ferrari MC Bonferoni C Muzzarelli C Caramella 2004 Assessment of chitosan derivatives as buccal and vaginal penetration enhancers Eur J Pharm Sci 21 351 9 10.1016/j.ejps.2003.10.028 1:CAS:528: DC%2BD2cXptFWqtQ%3D%3D 14757509 (Pubitemid 38156173)
22. VM Patel BG Prajapati MM Patel 2007 Design and characterization of chitosan-containing mucoadhesive buccal patches of propranolol hydrochloride Acta Pharm 57 61 72 10.2478/v10007-007-0005-9 1:CAS:528:DC%2BD2sXis1aks7w%3D 19839407 (Pubitemid 46361948)
23. SK Jain NK Jain Y Gupta A Jain D Jain M Chaurasia 2007 mucoadhesive chitosan microspheres for non-invasive and improved nasal delivery of insulin Ind J Pharm Sci 69 498 504 10.4103/0250-474X.36933 1:CAS:528:DC%2BD1MXhtVGqs7rP
24. C Eouani Ph Piccerelle P Prinderre E Bourret J Joachim 2001 In vitro comparative study of buccal mucoadhesive performance of different polymeric films Eur J Pharm Biopharm 52 45 55 10.1016/S0939-6411(01)00146-1 1:CAS:528:DC%2BD3MXkvVeksLs%3D 11438423 (Pubitemid 32600035)
25. LI Feng-Qian HU Jin-Hong JX Deng H Su S Xu JY Liu 2006 In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets Int J Pharm 324 152 7 10.1016/j.ijpharm.2006.06.006 (Pubitemid 44528916)
26. AA Obaidat RM Obaidat 2001 Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenate Eur J Pharm Biopharm 52 231 5 10.1016/S0939-6411(01)00173-4 1:CAS:528:DC%2BD3MXmtV2ktbs%3D 11522491 (Pubitemid 32755903)
27. NA Peppas 1985 Analysis of Fickian and non-Fickian drug release from polymers Pharm Acta Helv 60 110 11 1:CAS:528:DyaL2MXktFWgtb8%3D 4011621